XRAY / DENTSPLY SIRONA Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

June 30, 2025 December 31, 2024 Assets Current Assets: Cash and cash equivalents $ 359 $ 272 Accounts and notes receivable-trade, net 646 556 Inventories, net 675 564 Prepaid expenses and other current assets 286 354 Total Current Assets 1,966 1,746

Dentsply Sirona Reports Second Quarter 2025 Results •Net sales of $936 million decreased (4.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 August 7, 2025 Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 August 7, 2025 Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (C

Employment Agreement This Employment Agreement (this “Agreement”), is entered into as of July 18, 2025 (the “Effective Date”) by and between DENTSPLY SIRONA Inc., a Delaware corporation (the “Company”) and Daniel Scavilla (“Executive”) (collectively

Employment Agreement This Employment Agreement (this “Agreement”), is entered into as of July 18, 2025 (the “Effective Date”) by and between DENTSPLY SIRONA Inc.

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook CHARLOTTE, N.C., July 21, 2025 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq:

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook CHARLOTTE, N.

Separation and Release of Claims Agreement This Separation and Release of Claims Agreement (“Agreement”) is entered into by and between DENTSPLY SIRONA Inc., a Delaware corporation (“Employer”) and Simon D. Campion (“Executive”) (the Employer and the

Separation and Release of Claims Agreement This Separation and Release of Claims Agreement (“Agreement”) is entered into by and between DENTSPLY SIRONA Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 July 18, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 July 18, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Co

As filed with the Securities and Exchange Commission on July 1, 2025

As filed with the Securities and Exchange Commission on July 1, 2025 Registration No.

Table 1: Newly Registered Securities

Calculation of Filing Fee Tables S-8 DENTSPLY SIRONA Inc. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, $0.01 par value per share, reserved for issuance pursuant to the Registrant DENTSPLY SIRONA Inc. 2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 June 12, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 June 12, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation) (Commission file nu

Second Supplemental Indenture, dated as of June 12, 2025, between DENTSPLY SIRONA Inc. and Computershare Trust Company, N.A.

EX-4.2 Exhibit 4.2 DENTSPLY SIRONA INC. and COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee SECOND SUPPLEMENTAL INDENTURE Dated as of June 12, 2025 to INDENTURE Dated as of May 26, 2020 8.375% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2055 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 1.1 Definition of Terms 1 ARTICLE II GENERAL TERMS AND CONDITIONS OF THE NOTES 5 2.1

$550,000,000 8.375% Junior Subordinated Notes due 2055

Table of Contents Filed Pursuant to Rule 424(b)(2) Registration No. 333-286281 PROSPECTUS SUPPLEMENT (To Prospectus Dated March 31, 2025) $550,000,000 8.375% Junior Subordinated Notes due 2055 This is an offering by DENTSPLY SIRONA Inc. (“we”, “us” or “our”) of an aggregate of $550,000,000 of 8.375% Junior Subordinated Notes due 2055 (the “notes”). The notes will bear interest (i) from, and includ

Calculation of Filing Fee Tables Form 424(b)(2) (Form Type) DENTSPLY SIRONA INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities

Exhibit 107 Calculation of Filing Fee Tables Form 424(b)(2) (Form Type) DENTSPLY SIRONA INC.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 June 5, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation) (Commission file num

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes

Exhibit 99.1 Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes CHARLOTTE, N.C., June 5, 2025 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced it has priced an offering (the “Offering”) of $550 million aggregate principal amount of its 8.375% Junior Subordinated Notes due 2055 (the “notes”). The Offering is expect

Underwriting Agreement, dated June 5, 2025, between DENTSPLY SIRONA Inc. and Goldman Sachs & Co. LLC, as representative of the several underwriters named in Schedule II thereto

Exhibit 1.1 DENTSPLY SIRONA INC. US$550,000,000 8.375% Junior Subordinated Notes due 2055 UNDERWRITING AGREEMENT June 5, 2025 To the Manager named in Schedule I hereto for the Underwriters named in Schedule II hereto Ladies and Gentlemen: DENTSPLY SIRONA Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule II hereto (the “Underwrite

DENTSPLY SIRONA Inc. Pricing Term Sheet—June 5, 2025 $550,000,000 8.375% Junior Subordinated Notes due 2055 Issuer: DENTSPLY SIRONA Inc. (the “Issuer”) Description of Securities: $550,000,000 8.375% Junior Subordinated Notes due 2055 (the “Notes”) Ma

Filed pursuant to Rule 433 Free Writing Prospectus dated June 5, 2025 Registration Statement No.

Note Purchase and Guarantee Agreement Amendment No. 3, dated as of June 3, 2025, by and among DENTSPLY SIRONA Inc., Sirona Dental Services GmbH and each of the holders of Notes parties thereto, with respect to that certain Note Purchase and Guarantee Agreement, dated October 27, 2016, by and among DENTSPLY SIRONA Inc., Sirona Dental Services GmbH and the other parties thereto.

EX-4.3 Exhibit 4.3 Execution Version NOTE PURCHASE AND GUARANTEE AGREEMENT AMENDMENT NO. 3 This NOTE PURCHASE AND GUARANTEE AGREEMENT AMENDMENT NO. 3 (this “Agreement”), is dated as of June 3, 2025, by and among DENTSPLY SIRONA Inc., a Delaware corporation (the “Company”), Sirona Dental Services GmbH, a company with limited liability organized in the Federal Republic of Germany (the “German Issuer

Note Purchase Agreement Amendment No. 3, dated as of June 3, 2025, by and among DENTSPLY SIRONA Inc. and each of the holders of Notes parties thereto, with respect to that certain Note Purchase Agreement, dated December 11, 2015, by and among DENTSPLY SIRONA Inc. and the other parties thereto.

EX-4.2 Exhibit 4.2 Execution Version NOTE PURCHASE AGREEMENT AMENDMENT NO. 3 This NOTE PURCHASE AGREEMENT AMENDMENT NO. 3 (this “Agreement”), is dated as of June 3, 2025, by and among DENTSPLY SIRONA INC. (f/k/a DENTSPLY International Inc.), a Delaware corporation (the “Company”), and each of the holders of Notes (as defined below) whose names appear on the signature pages hereto (collectively, th

Note Purchase Agreement Amendment No. 3, dated as of June 3, 2025, by and among DENTSPLY SIRONA Inc. and each of the holders of Notes parties thereto, with respect to that certain Note Purchase Agreement, dated June 24, 2019, by and among DENTSPLY SIRONA Inc. and the other parties thereto.

EX-4.4 Exhibit 4.4 Execution Version NOTE PURCHASE AGREEMENT AMENDMENT NO. 3 This NOTE PURCHASE AGREEMENT AMENDMENT NO. 3 (this “Agreement”), is dated as of June 3, 2025, by and among DENTSPLY SIRONA INC., a Delaware corporation (the “Company”), and each of the holders of Notes (as defined below) whose names appear on the signature pages hereto (collectively, the “Noteholders”), with respect to th

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 June 3, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation) (Commission file num

First Amendment to Credit Agreement, dated as of June 3, 2025, by and among DENTSPLY SIRONA Inc, the financial institutions listed on the signature pages thereof as Lenders and JPMorgan Chase Bank, N.A., as administrative agent.

Exhibit 4.1 Execution Version FIRST AMENDMENT TO CREDIT AGREEMENT This FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of June 3, 2025, among DENTSPLY SIRONA Inc., a Delaware corporation (the “Company”), the financial institutions listed on the signature pages hereof as Lenders and JPMORGAN CHASE BANK, N.A., as administrative agent (the “Administrative Agent”). RECITALS: WHEREAS,

Subject to Completion, dated June 3, 2025

424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-286281 This prospectus supplement relates to an effective registration statement under the Securities Act of 1933, but is not complete and may be changed. This prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securities in any jur

1 Dentsply Sirona Inc. Conflict Minerals Report For the Year Ended December 31, 2024 Company Overview This report has been prepared by the management of DENTSPLY SIRONA Inc. (herein referred to as the “Company”, “Dentsply Sirona”, “we”, “us”, or “our

1 Dentsply Sirona Inc. Conflict Minerals Report For the Year Ended December 31, 2024 Company Overview This report has been prepared by the management of DENTSPLY SIRONA Inc. (herein referred to as the “Company”, “Dentsply Sirona”, “we”, “us”, or “our”). The information includes the activities of all majority-owned subsidiaries and variable interest entities that are required to be consolidated. Th

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of inco

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 13320 Ballantyne Corporate Place, Charlotte North Carolina 28

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 27, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Com

P a g e 1 | 3 May 15, 2025 Dentsply Sirona 13320-B Ballantyne Corporate Place Charlotte, NC 28277 Dear Matt, On behalf of Dentsply Sirona, I am pleased to offer you the role of Executive Vice President & Chief Financial Officer. In this role, you wil

P a g e 1 | 3 May 15, 2025 Dentsply Sirona 13320-B Ballantyne Corporate Place Charlotte, NC 28277 Dear Matt, On behalf of Dentsply Sirona, I am pleased to offer you the role of Executive Vice President & Chief Financial Officer.

Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer Charlotte, N.C., May 29, 2025 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Matthew E. Garth has been appointed Executive Vice Pres

Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer Charlotte, N.C., May 29, 2025 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Matthew E. Garth has been appointed Executive Vice President and Chief Financial Officer, effective May 30, 2025. Mr. Garth brings nearly 30 years of proven financial management expertise to Dentsply Siron

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 21, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Com

March 31, 2025 December 31, 2024 Assets Current Assets: Cash and cash equivalents $ 398 $ 272 Accounts and notes receivable-trade, net 604 556 Inventories, net 612 564 Prepaid expenses and other current assets 364 354 Total Current Assets 1,978 1,746

Dentsply Sirona Reports First Quarter 2025 Results •Net sales of $879 million decreased (7.

AMENDMENT TO THE DENTSPLY SIRONA INC. SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN WHEREAS, Dentsply Sirona Inc. (the "Company") maintains the Dentsply Sirona Inc. Supplemental Executive Retirement Plan (the "Plan"); WHEREAS, Section 9.1 of the Plan provid

AMENDMENT TO THE DENTSPLY SIRONA INC. SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN WHEREAS, Dentsply Sirona Inc. (the "Company") maintains the Dentsply Sirona Inc. Supplemental Executive Retirement Plan (the "Plan"); WHEREAS, Section 9.1 of the Plan provides that the Compensation & Human Capital Committee of the Board of Directors of the Company (the “Committee”) may amend the Plan at any time, provided

Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 8, 2025 Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Comm

Execution Version ASSIGNMENT AND ASSUMPTION and AMENDMENT TO CREDIT AGREEMENT This Assignment and Assumption and Amendment to Credit Agreement (the “Assignment and Assumption”) is dated as of the Effective Date set forth below and is entered into by

Execution Version ASSIGNMENT AND ASSUMPTION and AMENDMENT TO CREDIT AGREEMENT This Assignment and Assumption and Amendment to Credit Agreement (the “Assignment and Assumption”) is dated as of the Effective Date set forth below and is entered into by and between Goldman Sachs Bank USA (the “Assignor”), the Borrower identified below (the “Borrower”) and each Assignee identified in item 2 below (each, an “Assignee”).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934         Filed by the Registrant ☒     Filed by a Party other than the Registrant  ☐         Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))  

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934         Filed by the Registrant ☒     Filed by a Party other than the Registrant  ☐         Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934         Filed by the Registrant ☒     Filed by a Party other than the Registrant  ☐         Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by R

Statement of Eligibility on Form T-1 of trustee under the Indenture.

Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) N

Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) DENTSPLY SIRONA INC.

As filed with the Securities and Exchange Commission on March 31, 2025

Table of Contents As filed with the Securities and Exchange Commission on March 31, 2025 Registration No.

EXECUTION VERSION BRIDGE LOAN AGREEMENT dated as of March 19, 2025 among DENTSPLY SIRONA INC. The Lenders Party Hereto GOLDMAN SACHS BANK USA as Administrative Agent ____________________ GOLDMAN SACHS BANK USA as Sole Bookrunner and Sole Lead Arrange

EXECUTION VERSION BRIDGE LOAN AGREEMENT dated as of March 19, 2025 among DENTSPLY SIRONA INC.

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 March 19, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 o TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in

DENTSPLY SIRONA INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In millions, except per share amounts and percentages) (unaudited) Three Months Ended Year Ended December 31, December 31, 2024 2023 2024 2023 Net sales $ 905 $ 1,

Dentsply Sirona Reports Fourth Quarter and Full Year 2024 Results, Provides Full Year 2025 Outlook •FY24 net sales of $3,793 million decreased (4.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 February 27, 2025 Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

Subsidiaries of DENTSPLY SIRONA Inc. (the “Company”) - December 31, 2024

Exhibit 21.1 Subsidiaries of DENTSPLY SIRONA Inc. (the “Company”) - December 31, 2024 1.Byte AU Pty. Ltd. (Australia) 2.Byte AU Unit Trust (Australia) 3.Datum Biotech Ltd. (Israel) 4.Datum Dental Ltd. (Israel) 5.DeguDent GmbH (Germany) 6.Dentsply - Sirona Poland SP.z.o.o (Poland) 7.Dentsply (Tianjin) International Trading Co. Ltd. (China) 8.Dentsply Argentina S.A.C.e.I. (Argentina) 9.Dentsply BX S

Dentsply Sirona Initiates Review of Strategic Alternatives for Wellspect Healthcare Charlotte, N.C., February 11, 2025 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company has initiated a process

Dentsply Sirona Initiates Review of Strategic Alternatives for Wellspect Healthcare Charlotte, N.

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 February 11, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 February 5, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members Charlotte, N.C., February 6, 2025 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Michael J. Barber and Daniel T. Scavill

Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members Charlotte, N.

Dentsply Sirona Announces Repositioning of Byte within Aligner Portfolio Company to Present at J.P. Morgan Healthcare Conference Charlotte, N.C., January 14, 2025 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announ

Dentsply Sirona Announces Repositioning of Byte within Aligner Portfolio Company to Present at J.

J.P. Morgan Healthcare Conference Simon Campion President and Chief Executive Officer January 15, 2025 Forward-Looking Statements and Associated Risks This presentation contains statements that do not directly and exclusively relate to historical fac

J.P. Morgan Healthcare Conference Simon Campion President and Chief Executive Officer January 15, 2025 Forward-Looking Statements and Associated Risks This presentation contains statements that do not directly and exclusively relate to historical facts which constitute forward-looking statements, including, statements and projections concerning, among other things, the expected timing, benefits an

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 January 14, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

Dentsply Sirona Appoints Herman V. Cueto Interim Chief Financial Officer Charlotte, N.C., December 3, 2024 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Herman V. Cueto, a seasoned healthcare executiv

exhibit991interimcfopres Dentsply Sirona Appoints Herman V. Cueto Interim Chief Financial Officer Charlotte, N.C., December 3, 2024 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Herman V. Cueto, a seasoned healthcare executive, has been appointed Interim Chief Financial Officer, effective immediately. He brings over two decades of experience leadin

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 December 3, 2024 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

JOINT FILING AGREEMENT

EX-99.1 2 d847466dex991.htm EX-99.1 EXHIBIT 1 JOINT FILING AGREEMENT The undersigned hereby agree to the joint filing of the Schedule 13G to which this Agreement is attached. Dated: 11/12/2024 ARTISAN PARTNERS ASSET MANAGEMENT INC, for itself and as the general partner of ARTISAN PARTNERS HOLDINGS LP By: Gregory K. Ramirez * ARTISAN INVESTMENTS GP LLC, for itself and as the general partner of ARTI

XRAY / DENTSPLY SIRONA Inc. / Artisan Partners Limited Partnership - SC 13G/A Passive Investment

SC 13G/A 1 d847466dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to Rule 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2. Under the Securities Exchange Act of 1934 (Amendment No. 6 )* DENTSPLY SIRONA Inc. (Name of Issuer) Common Stock (Title of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 November 6, 2024 Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

September 30, 2024 December 31, 2023 Assets Current Assets: Cash and cash equivalents $ 296 $ 334 Accounts and notes receivable-trade, net 671 695 Inventories, net 619 624 Prepaid expenses and other current assets 335 320 Total Current Assets 1,921 1

Dentsply Sirona Reports Third Quarter 2024 Results •Net sales of $951 million increased 0.

Dentsply Sirona Provides Update on Byte Aligner Products Voluntarily Suspends Sales and Marketing of Byte Aligners and Impression Kits Provides Select Preliminary Third Quarter 2024 Results CHARLOTTE, N.C., -- Oct. 24, 2024 -- DENTSPLY SIRONA Inc. (“

a10242024-bytepressrelea Dentsply Sirona Provides Update on Byte Aligner Products Voluntarily Suspends Sales and Marketing of Byte Aligners and Impression Kits Provides Select Preliminary Third Quarter 2024 Results CHARLOTTE, N.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 October 24, 2024 Date of Report (Date of earliest event reported) DENTSPLY SIRONA I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 October 24, 2024 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

Dentsply Sirona Initiates Search for New CFO Glenn Coleman to Resign in November to Join Another Company Charlotte, N.C., August 20, 2024 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Executive Vice P

Dentsply Sirona Initiates Search for New CFO Glenn Coleman to Resign in November to Join Another Company Charlotte, N.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 August 15, 2024 Date of Report (Date of earliest event reported) DENTSPLY SIRONA In

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 August 15, 2024 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Costs Associated with Exit or Disposal Activities, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 July 29, 2024 Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Co

June 30, 2024 December 31, 2023 Assets Current Assets: Cash and cash equivalents $ 279 $ 334 Accounts and notes receivable-trade, net 591 695 Inventories, net 608 624 Prepaid expenses and other current assets 280 320 Total Current Assets 1,758 1,973

Dentsply Sirona Reports Second Quarter 2024 Results and Announces Second Phase of Transformation •Net sales of $984 million decreased (4.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact

Effective May 21, 2024 DENTSPLY SIRONA Inc. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY Purpose DENTSPLY SIRONA Inc. (the “Company") believes that the granting of compensation to its members of the Board of Directors (the “Board,” and members of the Bo

Effective May 21, 2024 DENTSPLY SIRONA Inc. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY Purpose DENTSPLY SIRONA Inc. (the “Company") believes that the granting of compensation to its members of the Board of Directors (the “Board,” and members of the Board, “Directors”) represents a powerful tool to attract, retain and reward Directors of the Company. This Director Compensation Policy (the “Policy”)

CASH-SETTLED RESTRICTED SHARE UNIT AWARD NOTICE UNDER THE DENTSPLY SIRONA INC. 2024 OMNIBUS INCENTIVE PLAN as amended and restated CASH-SETTLED RESTRICTED SHARE UNIT AWARD NOTICE Notice is hereby given of the following award of cash-settled Restricte

CASH-SETTLED RESTRICTED SHARE UNIT AWARD NOTICE UNDER THE DENTSPLY SIRONA INC. 2024 OMNIBUS INCENTIVE PLAN as amended and restated CASH-SETTLED RESTRICTED SHARE UNIT AWARD NOTICE Notice is hereby given of the following award of cash-settled Restricted Share Units (“Cash- Settled RSUs” and the “Award”), pursuant to which you may earn the right to receive cash payments equal to the Fair Market Value

PERFORMANCE RESTRICTED SHARE UNIT GRANT NOTICE UNDER THE DENTSPLY SIRONA INC. 2024 OMNIBUS INCENTIVE PLAN as amended and restated PERFORMANCE RESTRICTED SHARE UNIT GRANT NOTICE Notice is hereby given of the following award of Restricted Share Units (

PERFORMANCE RESTRICTED SHARE UNIT GRANT NOTICE UNDER THE DENTSPLY SIRONA INC. 2024 OMNIBUS INCENTIVE PLAN as amended and restated PERFORMANCE RESTRICTED SHARE UNIT GRANT NOTICE Notice is hereby given of the following award of Restricted Share Units (the “Award”), pursuant to which the Grantee may earn the right to receive one share of the Common Stock, $0.01 par value per share, of DENTSPLY SIRONA

CASH-SETTLED PERFORMANCE RESTRICTED SHARE UNIT AWARD NOTICE UNDER THE DENTSPLY SIRONA INC. 2024 OMNIBUS INCENTIVE PLAN as amended and restated CASH-SETTLED PERFORMANCE RESTRICTED SHARE UNIT AWARD NOTICE Notice is hereby given of the following award o

CASH-SETTLED PERFORMANCE RESTRICTED SHARE UNIT AWARD NOTICE UNDER THE DENTSPLY SIRONA INC.

OPTION GRANT NOTICE UNDER THE DENTSPLY SIRONA INC. 2024 OMNIBUS INCENTIVE PLAN as amended and restated OPTION GRANT NOTICE Notice is hereby given of the following option grant (the “Option”) to purchase Common Stock, $0.01 par value per share, of DEN

OPTION GRANT NOTICE UNDER THE DENTSPLY SIRONA INC. 2024 OMNIBUS INCENTIVE PLAN as amended and restated OPTION GRANT NOTICE Notice is hereby given of the following option grant (the “Option”) to purchase Common Stock, $0.01 par value per share, of DENTSPLY SIRONA Inc. (“Common Shares” or “Shares”) pursuant to the following terms and conditions: • Optionee: [Participant Name] • Grant Date: [Grant Da

RESTRICTED SHARE UNIT GRANT NOTICE UNDER THE DENTSPLY SIRONA INC. 2024 OMNIBUS INCENTIVE PLAN as amended and restated RESTRICTED SHARE UNIT GRANT NOTICE Notice is hereby given of the following award of Restricted Share Units (the “Award”), pursuant t

RESTRICTED SHARE UNIT GRANT NOTICE UNDER THE DENTSPLY SIRONA INC. 2024 OMNIBUS INCENTIVE PLAN as amended and restated RESTRICTED SHARE UNIT GRANT NOTICE Notice is hereby given of the following award of Restricted Share Units (the “Award”), pursuant to which the Grantee may earn the right to receive one share of the Common Stock, $0.01 par value per share, of DENTSPLY SIRONA Inc. (“Common Shares”)

Dentsply Sirona Inc. Conflict Minerals Report For the Year Ended December 31, 2023 Company Overview This report has been prepared by the management of DENTSPLY SIRONA Inc. (herein referred to as the “Company”, “Dentsply Sirona”, “we”, “us”, or “our”)

Dentsply Sirona Inc. Conflict Minerals Report For the Year Ended December 31, 2023 Company Overview This report has been prepared by the management of DENTSPLY SIRONA Inc. (herein referred to as the “Company”, “Dentsply Sirona”, “we”, “us”, or “our”). The information includes the activities of all majority-owned subsidiaries and variable interest entities that are required to be consolidated. The

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of inco

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 13320 Ballantyne Corporate Place, Charlotte North Carolina 28

Calculation of Filing Fee Table Form S-8 DENTSPLY SIRONA Inc. Table 1: Newly Registered Securities

Exhibit 107 Calculation of Filing Fee Table Form S-8 DENTSPLY SIRONA Inc. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price (2) Fee Rate Amount of Registration Fee Equity Common Stock, $0.01 par value per share, reserved for issuance pursuant to the Registr

DENTSPLY SIRONA INC. AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN Approved by the Board on April 9, 2024 Table of Contents SECTION 1 Purpose and Term 1 1.1 Purpose 1 1.2 Term of the Plan 1 SECTION 2 Definitions 1 2.1 Definitions 1 2.2 Constructi

DENTSPLY SIRONA INC. AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN Approved by the Board on April 9, 2024 Table of Contents SECTION 1 Purpose and Term 1 1.1 Purpose 1 1.2 Term of the Plan 1 SECTION 2 Definitions 1 2.1 Definitions 1 2.2 Construction 3 SECTION 3 Eligibility and Participation 4 3.1 Eligibility 4 3.2 Participation 4 3.3 Termination of Employment or Loss of Eligibility 4 3.4 Hardsh

DENTSPLY SIRONA INC. 2024 OMNIBUS INCENTIVE PLAN Section 1. Purpose of Plan. DENTSPLY SIRONA Inc. (“Company”) hereby approves the DENTSPLY SIRONA Inc. 2024 Omnibus Incentive Plan (the “Plan”). This Plan was approved by the Board on April 9, 2024, and

DENTSPLY SIRONA INC. 2024 OMNIBUS INCENTIVE PLAN Section 1. Purpose of Plan. DENTSPLY SIRONA Inc. (“Company”) hereby approves the DENTSPLY SIRONA Inc. 2024 Omnibus Incentive Plan (the “Plan”). This Plan was approved by the Board on April 9, 2024, and will become effective upon the date on which the Plan is approved by the stockholders of the Company (the “Effective Date”). The purpose of the Plan

As filed with the Securities and Exchange Commission on May 24, 2024

As filed with the Securities and Exchange Commission on May 24, 2024 Registration No.

RESTRICTED SHARE UNIT GRANT NOTICE UNDER THE DENTSPLY SIRONA INC. 2024 OMNIBUS INCENTIVE PLAN as amended and restated RESTRICTED SHARE UNIT GRANT NOTICE (for Directors) Notice is hereby given of the following award of Restricted Share Units (the “Awa

RESTRICTED SHARE UNIT GRANT NOTICE UNDER THE DENTSPLY SIRONA INC. 2024 OMNIBUS INCENTIVE PLAN as amended and restated RESTRICTED SHARE UNIT GRANT NOTICE (for Directors) Notice is hereby given of the following award of Restricted Share Units (the “Award”), which entitles the Grantee to receive one share of the Common Shares, $0.01 par value per share, of DENTSPLY SIRONA Inc. (“Common Shares” or “Sh

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 22, 2024 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exac

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 2, 2024 Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Comm

March 31, 2024 December 31, 2023 Assets Current Assets: Cash and cash equivalents $ 291 $ 334 Accounts and notes receivable-trade, net 656 695 Inventories, net 613 624 Prepaid expenses and other current assets 342 320 Total Current Assets 1,902 1,973

Dentsply Sirona Reports First Quarter 2024 Results •Net sales of $953 million decreased (2.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Stat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ D

March 7, 2024 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by DENTSPLY SIRONA Inc. pursuant to Item 4.01 of Form 8-K (copy attached), which we understand will be filed with

March 7, 2024 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by DENTSPLY SIRONA Inc. pursuant to Item 4.01 of Form 8-K (copy attached), which we understand will be filed with the Securities and Exchange Commission as part of the Current Report on Form 8-K of DENTSPLY SIRONA Inc. dated March 4, 2024. We agree with the state

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 March 4, 2024 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 o TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in

Subsidiaries of DENTSPLY SIRONA Inc. (the “Company”) - December 31, 2023

Exhibit 21.1 Subsidiaries of DENTSPLY SIRONA Inc. (the “Company”) - December 31, 2023 1.Augma Bio Materials Ltd. (Israel, 20%) 2.Barracuda Partners, L.P. (Delaware, 25%) 3.Byte AU Pty. Ltd. (Australia) 4.Byte AU Unit Trust (Australia) 5.Byteme Aligners Limited (United Kingdom) 6.Clear Blue Smiles, Inc. (Delaware, 15%) 7.Datum Biotech Ltd. (Israel) 8.Datum Dental Ltd. (Israel) 9.DeguDent GmbH (Germ

Effective July 27, 2023 DENTSPLY SIRONA Inc. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY Purpose DENTSPLY SIRONA Inc. (the “Company") believes that the granting of compensation to its members of the Board of Directors (the “Board,” and members of the B

Effective July 27, 2023 DENTSPLY SIRONA Inc. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY Purpose DENTSPLY SIRONA Inc. (the “Company") believes that the granting of compensation to its members of the Board of Directors (the “Board,” and members of the Board, “Directors”) represents a powerful tool to attract, retain and reward Directors of the Company. This Director Compensation Policy (the “Policy”)

INDEMNIFICATION AGREEMENT This Indemnification Agreement, dated as of __________ __, 20__, is made by and between DENTSPLY SIRONA INC., a Delaware corporation (the “Corporation”) and __________________ (the “Indemnitee”). RECITALS A. The Corporation

INDEMNIFICATION AGREEMENT This Indemnification Agreement, dated as of , 20, is made by and between DENTSPLY SIRONA INC.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 February 29, 2024 Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

Dentsply Sirona Announces Retirement of Eric K. Brandt from the Board of Directors Charlotte, N.C., February 29, 2024 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Eric K. Brandt, who has served as a

Dentsply Sirona Announces Retirement of Eric K. Brandt from the Board of Directors Charlotte, N.C., February 29, 2024 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Eric K. Brandt, who has served as a Director on the Company’s Board of Directors (the “Board”) for nearly twenty years and as Chairman of the Board for six years, has informed the Board

DENTSPLY SIRONA INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In millions, except per share amounts and percentages) (unaudited) Three Months Ended Year Ended December 31, December 31, 2023 2022 2023 2022 Net sales $ 1,012 $

Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Provides Full Year 2024 Outlook, Raises Dividend •FY23 net sales of $3,965 million increased 1.

DENTSPLY SIRONA INC. DODD-FRANK ACT RESTATEMENT CLAWBACK POLICY Date: November 21, 2023 Purpose The Board of Directors (the "Board") of DENTSPLY SIRONA Inc. (the “Company”) has adopted this Dodd- Frank Act Restatement Clawback Policy, as it may be am

DENTSPLY SIRONA INC. DODD-FRANK ACT RESTATEMENT CLAWBACK POLICY Date: November 21, 2023 Purpose The Board of Directors (the "Board") of DENTSPLY SIRONA Inc. (the “Company”) has adopted this Dodd- Frank Act Restatement Clawback Policy, as it may be amended from time to time (the “Policy”) in order to comply with the Clawback Rules. The purpose of this Policy is to describe the circumstances in whic

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 February 29, 2024 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

9080‐POL‐0001 Revised July 26, 2022 Insider Trading Policy I. INTRODUCTION DENTSPLY SIRONA Inc. (together with its subsidiaries and affiliates, “DENTSPLY SIRONA” or the “Company”) has adopted this Policy to promote compliance by the Company, its dire

9080‐POL‐0001 Revised July 26, 2022 Insider Trading Policy I. INTRODUCTION DENTSPLY SIRONA Inc. (together with its subsidiaries and affiliates, “DENTSPLY SIRONA” or the “Company”) has adopted this Policy to promote compliance by the Company, its directors and personnel with the federal and state securities laws, which, among other things, prohibit purchases or sales of securities of the Company (o

XRAY / DENTSPLY SIRONA Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 14)* Name of issuer: DENTSPLY SIRONA Inc Title of Class of Securities: Common Stock CUSIP Number: 24906P109 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

JOINT FILING AGREEMENT

EX-99.1 2 d767530dex991.htm EX-99.1 EXHIBIT 1 JOINT FILING AGREEMENT The undersigned hereby agree to the joint filing of the Schedule 13G to which this Agreement is attached. Dated: 2/12/2024 ARTISAN PARTNERS ASSET MANAGEMENT INC, for itself and as the general partner of ARTISAN PARTNERS HOLDINGS LP By: Gregory K. Ramirez * ARTISAN INVESTMENTS GP LLC, for itself and as the general partner of ARTIS

XRAY / DENTSPLY SIRONA Inc. / Artisan Partners Limited Partnership - SC 13G/A Passive Investment

SC 13G/A 1 d767530dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to Rule 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2. Under the Securities Exchange Act of 1934 (Amendment No. 5)* DENTSPLY SIRONA Inc. (Name of Issuer) Common Stock (Title of Class of Secur

XRAY / DENTSPLY SIRONA Inc. / NUANCE INVESTMENTS, LLC - NUANCE INVESTMENTS LLC Passive Investment

SC 13G/A 1 xraya120524.htm NUANCE INVESTMENTS LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* DENTSPLY SIRONA (Name of Issuer) COMMON (Title of Class of Securities) 24906P109 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to desig

Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2023 Results Charlotte, N.C., January 9, 2024 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will present at the 42n

Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2023 Results Charlotte, N.C., January 9, 2024 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET). As part of the conference, the Company is prov

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 January 9, 2024 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (

J.P. Morgan Healthcare Conference Simon Campion President and Chief Executive Officer January 10, 2024 Forward-Looking Statements and Associated Risks This presentation contains statements that do not directly and exclusively relate to historical fac

ex992-01102024xrayjpmhea J.P. Morgan Healthcare Conference Simon Campion President and Chief Executive Officer January 10, 2024 Forward-Looking Statements and Associated Risks This presentation contains statements that do not directly and exclusively relate to historical facts which constitute forward-looking statements, including, statements and projections concerning, among other things, the exp

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 November 9, 2023 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

Dentsply Sirona to Host its Investor Day and Introduce Three-Year Financial Targets Charlotte, N.C., November 9, 2023 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will host its Investor Day today at the Company’s headqua

Dentsply Sirona to Host its Investor Day and Introduce Three-Year Financial Targets Charlotte, N.

2023 Investor Day November 9, 2023 Charlotte, NC Welcome and Opening Remarks Andrea Daley VP, Investor Relations November 9, 2023 Forward-Looking Statements and Associated Risks This presentation contains statements that do not directly and exclusive

2023 Investor Day November 9, 2023 Charlotte, NC Welcome and Opening Remarks Andrea Daley VP, Investor Relations November 9, 2023 Forward-Looking Statements and Associated Risks This presentation contains statements that do not directly and exclusively relate to historical facts which constitute forward-looking statements, including, statements and projections concerning, among other things, the expected timing, benefits and costs associated with the Company’s restructuring plan described in this presentation.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (

Dentsply Sirona Announces Appointment of Mr. Brian Gladden as New Board Member Charlotte, N.C., November 2, 2023 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Mr. Brian Gladden has been appointed to i

ex993boardappointment Dentsply Sirona Announces Appointment of Mr. Brian Gladden as New Board Member Charlotte, N.C., November 2, 2023 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Mr. Brian Gladden has been appointed to its Board of Directors (the “Board”), effective January 1, 2024, to fill the vacancy from Mr. Harry M. Jansen Kraemer, Jr.’s reti

Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Net sales $ 947 $ 947 $ 2,953 $ 2,939 Cost of products sold 452 439 1,389 1,329 Gross profit 495 508 1,564 1,610 Selling, general, and administrative expenses 372 40

Dentsply Sirona Reports Third Quarter 2023 Results •Net sales of $947 million were flat year-over-year, organic sales decreased (0.

DENTSPLY SIRONA Inc. Supplemental Unaudited Financial Data for the Year Ended December 31, 2021 and Year Ended December 31, 2022 ($ in millions) Segment Information As previously announced, DENTSPLY SIRONA Inc. (the “Company”) made certain changes in

ex992dssupplementalsegme DENTSPLY SIRONA Inc. Supplemental Unaudited Financial Data for the Year Ended December 31, 2021 and Year Ended December 31, 2022 ($ in millions) Segment Information As previously announced, DENTSPLY SIRONA Inc. (the “Company”) made certain changes in the reporting structure for its global business units effective April 1, 2023 which resulted in a change in reportable segme

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 November 2, 2023 Date of Report (date of earliest event reported) DENTSPLY SIRONA I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 November 2, 2023 Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 24, 2023 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 24, 2023 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 September 29, 2023 Date of Report (Date of earliest event reported) DENTSPLY SIRONA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 September 29, 2023 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization

Dentsply Sirona Announces Planned Board Succession Charlotte, N.C., September 29, 2023 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that, as part of its planned succession process and consistent with the

ex991-chairmanappointmen Dentsply Sirona Announces Planned Board Succession Charlotte, N.

September 28, 2023 VIA EDGAR SUBMISSION U.S. Securities & Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, NE Washington, DC Attn: Julie Sherman and Brian Cascio Re: DENTSPLY SIRONA Inc.

September 28, 2023 VIA EDGAR SUBMISSION U.S. Securities & Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, NE Washington, DC Attn: Julie Sherman and Brian Cascio Re: DENTSPLY SIRONA Inc. Form 10-K for the Fiscal Year Ended December 31, 2022 Filed March 1, 2023 Form 8-K Dated August 2, 2023 Filed August 2, 2023 File No. 000-16211 Dear

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 September 10, 2023 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 o TRANSITION REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registra

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION R

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY

DENTSPLY SIRONA Inc. Supplemental Unaudited Financial Data for the Year Ended December 31, 2022 and Quarter Ended March 31, 2023 ($ in millions) Segment Information In conjunction with the restructuring plan announced in February 2023, DENTSPLY SIRON

ex992dssupplementalsegme DENTSPLY SIRONA Inc. Supplemental Unaudited Financial Data for the Year Ended December 31, 2022 and Quarter Ended March 31, 2023 ($ in millions) Segment Information In conjunction with the restructuring plan announced in February 2023, DENTSPLY SIRONA Inc. (the “Company”) made certain changes in the reporting structure for its global business units effective April 1, 2023

Regulation FD Disclosure, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 August 2, 2023 Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (C

Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Net sales $ 1,028 $ 1,023 $ 2,006 $ 1,992 Cost of products sold 478 442 937 890 Gross profit 550 581 1,069 1,102 Selling, general, and administrative expenses 416 410 832 786 R

Dentsply Sirona Reports Second Quarter 2023 Results •Net sales increased 0.5% to $1,028 million, organic sales increased 2.3% •GAAP net income of $86 million, GAAP earnings per share of $0.40 •Adjusted EBITDA margin of 17.7%, adjusted EPS of $0.51 •Raising midpoint of FY23 net sales by $75 million to a range of $3.98 billion to $4.02 billion •Raising FY23 organic sales growth outlook to approximat

Seventh Amended and Restated By-Laws (incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed on August 2, 2023).

ex31seventhamendedandres DENTSPLY SIRONA INC. SEVENTH AMENDED AND RESTATED BY-LAWS TABLE OF CONTENTS Page ARTICLE I STOCKHOLDERS’ MEETINGS ...............................................................................1 Section 1. Annual Meetings ............................................................................................... 1 Section 2. Special Meetings ...........................

DENTSPLY SIRONA Inc. Conflict Minerals Report For the Year Ended December 31, 2022 Company Overview This report has been prepared by the management of DENTSPLY SIRONA Inc. (herein referred to as the “Company”, “Dentsply Sirona”, “we”, “us”, or “our”)

EX-1.01 2 formsdcmr2022.htm EX-1.01 DENTSPLY SIRONA Inc. Conflict Minerals Report For the Year Ended December 31, 2022 Company Overview This report has been prepared by the management of DENTSPLY SIRONA Inc. (herein referred to as the “Company”, “Dentsply Sirona”, “we”, “us”, or “our”). The information includes the activities of all majority-owned subsidiaries and variable interest entities that a

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of inco

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 13320 Ballantyne Corporate Place, Charlotte North Carolina 28

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 24, 2023 (May 24, 2023) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or org

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 12, 2023 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Com

EXECUTION COPY CREDIT AGREEMENT dated as of May 12, 2023 among DENTSPLY SIRONA INC. The Subsidiary Borrowers Party Hereto The Lenders Party Hereto JPMORGAN CHASE BANK, N.A. as Administrative Agent CITIBANK, N.A. as Syndication Agent and BANK OF AMERI

exhibit101 EXECUTION COPY CREDIT AGREEMENT dated as of May 12, 2023 among DENTSPLY SIRONA INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exac

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 3, 2023 Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Comm

Dentsply Sirona Reports First Quarter 2023 Results

Dentsply Sirona Reports First Quarter 2023 Results •Net sales increased 0.9% to $978 million, organic sales increased 5.1% •GAAP net loss of ($19) million, GAAP loss per share of ($0.09) •Adjusted EBITDA of $161 million, adjusted EPS of $0.39 •Raising low-end of FY23 net sales outlook by $50 million and low-end of organic sales growth outlook by 100 basis points •Raising low-end of FY23 adjusted E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

DEFA14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 April 12, 2023 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 April 12, 2023 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (C

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 March 6, 2023 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Co

Dentsply Sirona Announces $150 Million Accelerated Share Repurchase Program CHARLOTTE, N.C., March 6, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that it has entered into an accele

exhibit991 Dentsply Sirona Announces $150 Million Accelerated Share Repurchase Program CHARLOTTE, N.

Subsidiaries of DENTSPLY SIRONA Inc. (the “Company”) - December 31, 2022

Exhibit 21.1 Subsidiaries of DENTSPLY SIRONA Inc. (the “Company”) - December 31, 2022 1. Augma Bio Materials Ltd. (Israel, 20%) 2. Barracuda Partners, L.P. (Delaware, 100%) 3. Byte AU Pty. Ltd. (Australia) 4. Byte AU Unit Trust (Australia) 5. Byte LLC (Nevada) 6. Byteme Aligners Limited (United Kingdom) 7. Datum Biotech Ltd. (Israel) 8. Datum Dental Ltd. (Israel) 9. DeguDent GmbH (Germany) 10. Den

INDEMNIFICATION AGREEMENT This Indemnification Agreement, dated as of __________ __, 20__, is made by and between DENTSPLY SIRONA INC., a Delaware corporation (the “Corporation”) and __________________ (the “Indemnitee”). RECITALS A. The Corporation

indemnificationagreement INDEMNIFICATION AGREEMENT This Indemnification Agreement, dated as of , 20, is made by and between DENTSPLY SIRONA INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 o TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 February 28, 2023 Date of Report (date of earliest event reported) DENTSPLY SIRONA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 February 28, 2023 Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

Dentsply Sirona Reports Fourth Quarter and Full Year 2022 Results, Provides Full Year 2023 Outlook

Dentsply Sirona Reports Fourth Quarter and Full Year 2022 Results, Provides Full Year 2023 Outlook •FY22 net sales decreased (7.

Dentsply Sirona Announces Organizational Changes to Simplify Structure, Enhance Profitability, Improve Operational Performance and Drive Growth Expects to Achieve $200 to $225 million in Annual Cost Savings Portfolio Evaluation and Simplification Pla

Dentsply Sirona Announces Organizational Changes to Simplify Structure, Enhance Profitability, Improve Operational Performance and Drive Growth Expects to Achieve $200 to $225 million in Annual Cost Savings Portfolio Evaluation and Simplification Plan Ongoing CHARLOTTE, N.

Regulation FD Disclosure, Financial Statements and Exhibits, Costs Associated with Exit or Disposal Activities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 February 16, 2023 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

XRAY / DENTSPLY SIRONA Inc / GENERATION INVESTMENT MANAGEMENT LLP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.

XRAY / DENTSPLY SIRONA Inc / Artisan Partners Limited Partnership - SC 13G/A Passive Investment

SC 13G/A SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to Rule 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2.

XRAY / DENTSPLY SIRONA Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv0723-dentsplysironainc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer: Dentsply Sirona Inc. Title of Class of Securities: Common Stock CUSIP Number: 24906P109 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to desig

XRAY / DENTSPLY SIRONA Inc / NUANCE INVESTMENTS, LLC - NUANCE INVESTMENTS LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 DENTSPLY SIRONA (Name of Issuer) COMMON (Title of Class of Securities) 24906P109 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-

Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2022 Results CHARLOTTE, N.C., January 11, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) will

Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2022 Results CHARLOTTE, N.C., January 11, 2023 (GLOBE NEWSWIRE) - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 10:30 am PT (1:30 pm ET). As part of the conference, t

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 January 11, 2023 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

CONSENT MEMORANDUM TO: DENTSPLY Sirona Inc. Lender Group RE: Consent re: Quarterly Financial Statements Extension DATE: October 28, 2022 Reference is hereby made to that certain Credit Agreement dated as of July 27, 2018 (as amended or otherwise modi

CONSENT MEMORANDUM TO: DENTSPLY Sirona Inc. Lender Group RE: Consent re: Quarterly Financial Statements Extension DATE: October 28, 2022 Reference is hereby made to that certain Credit Agreement dated as of July 27, 2018 (as amended or otherwise modified from time to time, the ?Credit Agreement?) by and among DENTSPLY Sirona Inc. (the ?Company?), the Subsidiary Borrowers from time to time party th

CONSENT MEMORANDUM TO: DENTSPLY Sirona Inc. Lender Group RE: Consent re: Quarterly Financial Statements Extension DATE: August 11, 2022 Reference is hereby made to that certain Credit Agreement dated as of July 27, 2018 (as amended or otherwise modif

CONSENT MEMORANDUM TO: DENTSPLY Sirona Inc. Lender Group RE: Consent re: Quarterly Financial Statements Extension DATE: August 11, 2022 Reference is hereby made to that certain Credit Agreement dated as of July 27, 2018 (as amended or otherwise modified from time to time, the ?Credit Agreement?) by and among DENTSPLY Sirona Inc. (the ?Company?), the Subsidiary Borrowers from time to time party the

Execution Version NOTE PURCHASE AGREEMENT AMENDMENT NO. 2 AND CONSENT This NOTE PURCHASE AGREEMENT AMENDMENT NO. 2 AND CONSENT (this “Agreement”), is dated as of November 5, 2022, by and among DENTSPLY SIRONA Inc. (f/k/a DENTSPLY International Inc.),

Execution Version NOTE PURCHASE AGREEMENT AMENDMENT NO. 2 AND CONSENT This NOTE PURCHASE AGREEMENT AMENDMENT NO. 2 AND CONSENT (this ?Agreement?), is dated as of November 5, 2022, by and among DENTSPLY SIRONA Inc. (f/k/a DENTSPLY International Inc.), a Delaware corporation (the ?Company?), and each of the holders of Notes (as defined below) whose names appear on the signature pages hereto (collect

Execution Version DB1/ 133670879.6 NOTE PURCHASE AGREEMENT AMENDMENT NO. 2 AND CONSENT This NOTE PURCHASE AGREEMENT AMENDMENT NO. 2 AND CONSENT (this “Agreement”), is dated as of November 5, 2022, by and among DENTSPLY SIRONA Inc., a Delaware corpora

Execution Version DB1/ 133670879.6 NOTE PURCHASE AGREEMENT AMENDMENT NO. 2 AND CONSENT This NOTE PURCHASE AGREEMENT AMENDMENT NO. 2 AND CONSENT (this ?Agreement?), is dated as of November 5, 2022, by and among DENTSPLY SIRONA Inc., a Delaware corporation (the ?Company?), and each of the holders of Notes (as defined below) whose names appear on the signature pages hereto (collectively, the ?Notehol

Execution Version DB1/ 133575378.2 NOTE PURCHASE AND GUARANTEE AGREEMENT AMENDMENT NO. 2 AND CONSENT This NOTE PURCHASE AND GUARANTEE AGREEMENT AMENDMENT NO. 2 AND CONSENT (this “Agreement”), is dated as of November 5, 2022, by and among DENTSPLY SIR

Execution Version DB1/ 133575378.2 NOTE PURCHASE AND GUARANTEE AGREEMENT AMENDMENT NO. 2 AND CONSENT This NOTE PURCHASE AND GUARANTEE AGREEMENT AMENDMENT NO. 2 AND CONSENT (this ?Agreement?), is dated as of November 5, 2022, by and among DENTSPLY SIRONA Inc., a Delaware corporation (the ?Company?), Sirona Dental Services GmbH, a company with limited liability organized in the Federal Republic of G

CONSENT MEMORANDUM TO: DENTSPLY Sirona Inc. Lender Group RE: Consent re: Quarterly Financial Statements Extension DATE: September 14, 2022 Reference is hereby made to that certain Credit Agreement dated as of July 27, 2018 (as amended or otherwise mo

CONSENT MEMORANDUM TO: DENTSPLY Sirona Inc. Lender Group RE: Consent re: Quarterly Financial Statements Extension DATE: September 14, 2022 Reference is hereby made to that certain Credit Agreement dated as of July 27, 2018 (as amended or otherwise modified from time to time, the ?Credit Agreement?) by and among DENTSPLY Sirona Inc. (the ?Company?), the Subsidiary Borrowers from time to time party

Execution Version NOTE PURCHASE AGREEMENT AMENDMENT AND CONSENT This NOTE PURCHASE AGREEMENT AMENDMENT AND CONSENT (this “Agreement”), is dated as of August 26, 2022, by and among DENTSPLY SIRONA Inc., a Delaware corporation (the “Company”), and each

Execution Version NOTE PURCHASE AGREEMENT AMENDMENT AND CONSENT This NOTE PURCHASE AGREEMENT AMENDMENT AND CONSENT (this ?Agreement?), is dated as of August 26, 2022, by and among DENTSPLY SIRONA Inc.

1 AMENDED & RESTATED DENTSPLY SIRONA INC. KEY EMPLOYEE SEVERANCE BENEFITS PLAN (Effective as of September 22, 2022) ARTICLE 1. INTRODUCTION 1.1. Establishment, Effective Date and Purpose. Dentsply Sirona Inc. (the “Company”) adopted the Dentsply Siro

1 AMENDED & RESTATED DENTSPLY SIRONA INC. KEY EMPLOYEE SEVERANCE BENEFITS PLAN (Effective as of September 22, 2022) ARTICLE 1. INTRODUCTION 1.1. Establishment, Effective Date and Purpose. Dentsply Sirona Inc. (the ?Company?) adopted the Dentsply Sirona Inc. Key Employee Severance Benefits Plan (the ?Plan?) originally effective as of May 25, 2022 and amended and restated effective as of September 2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 November 14, 2022 Date of Report (date of earliest event reported) DENTSPLY SIRONA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 November 14, 2022 Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

Execution Version NOTE PURCHASE AND GUARANTEE AGREEMENT AMENDMENT AND CONSENT This NOTE PURCHASE AND GUARANTEE AGREEMENT AMENDMENT AND CONSENT (this “Agreement”), is dated as of August 26, 2022, by and among DENTSPLY SIRONA Inc., a Delaware corporati

Execution Version NOTE PURCHASE AND GUARANTEE AGREEMENT AMENDMENT AND CONSENT This NOTE PURCHASE AND GUARANTEE AGREEMENT AMENDMENT AND CONSENT (this ?Agreement?), is dated as of August 26, 2022, by and among DENTSPLY SIRONA Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (

Execution Version NOTE PURCHASE AGREEMENT AMENDMENT AND CONSENT This NOTE PURCHASE AGREEMENT AMENDMENT AND CONSENT (this “Agreement”), is dated as of August 26, 2022, by and among DENTSPLY SIRONA Inc. (f/k/a DENTSPLY International Inc.), a Delaware c

Execution Version NOTE PURCHASE AGREEMENT AMENDMENT AND CONSENT This NOTE PURCHASE AGREEMENT AMENDMENT AND CONSENT (this ?Agreement?), is dated as of August 26, 2022, by and among DENTSPLY SIRONA Inc.

Dentsply Sirona Reports Third Quarter 2022 Results

Dentsply Sirona Reports Third Quarter 2022 Results •Net sales decreased (8.9%) to $947 million, organic sales decreased (0.7%) •GAAP EPS loss of ($5.01), adjusted EPS of $0.41 down (31.5%) year-over-year •Operating cash flow of $109 million •Updated FY22 outlook: organic sales decline of ~(2%); adj. EPS range of $1.90 to $2.00 Charlotte, N.C., November 14, 2022 - DENTSPLY SIRONA Inc. (“Dentsply Si

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 November 10, 2022 (November 4, 2022) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 0-16211 CUSIP NUMBER: 24906P109 (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: September 30, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Tr

Non-GAAP Financial Measures that Supplement US GAAP Measures DENTSPLY SIRONA Inc. (the “Company”) is providing the following tables to present certain non-GAAP information for the reporting periods covered in Amendment No. 1 to the Company’s Annual R

Non-GAAP Financial Measures that Supplement US GAAP Measures DENTSPLY SIRONA Inc. (the ?Company?) is providing the following tables to present certain non-GAAP information for the reporting periods covered in Amendment No. 1 to the Company?s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2021 (the ?Form 10- K/A?) as well as the Quarterly Reports on Form 10-Q for the quarters e

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 November 9, 2022 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registra

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact

Financial Statements and Exhibits, Material Impairments, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 29, 2022 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation) (Commission File

Dentsply Sirona Completes Internal Investigation Announces Restatements of Third Quarter 2021 and Full Year 2021 Financials Reports Select Preliminary Third Quarter 2022 Results

Exhibit 99.1 Dentsply Sirona Completes Internal Investigation Announces Restatements of Third Quarter 2021 and Full Year 2021 Financials Reports Select Preliminary Third Quarter 2022 Results CHARLOTTE, N.C., November 1, 2022 (GLOBE NEWSWIRE) - DENTSPLY SIRONA Inc. (?Dentsply Sirona? or ?the Company?) (Nasdaq: XRAY) today announced the completion of the previously disclosed internal investigation i

Dentsply Sirona Appoints Glenn Coleman as Chief Financial Officer CHARLOTTE, N.C., September 22, 2022 (GLOBE NEWSWIRE) – DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that Glenn Coleman has been appointed Ex

Dentsply Sirona Appoints Glenn Coleman as Chief Financial Officer CHARLOTTE, N.C., September 22, 2022 (GLOBE NEWSWIRE) ? DENTSPLY SIRONA Inc. (?Dentsply Sirona? or the ?Company?) (Nasdaq: XRAY) today announced that Glenn Coleman has been appointed Executive Vice President and Chief Financial Officer, effective September 26, 2022. He succeeds Barbara Bodem, who has served as Interim Chief Financial

Dentsply Sirona

Dentsply Sirona 13320-B Ballantyne Corporate Place Charlotte, NC 28277 September 22, 2022 Glenn Coleman 17 Carlisle Court Chester, NJ 07930 Glenncoleman1@comcast.

FIRST AMENDMENT TO THE EMPLOYMENT AGREEMENT

FIRST AMENDMENT TO THE EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO THE EMPLOYMENT AGREEMENT (this ?Amendment?), dated as of September 22, 2022 (the ?Amendment Date?), is entered into by and between Dentsply Sirona Inc.

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 September 22, 2022 (September 20, 2022) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorpor

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 September 2, 2022 (September 1, 2022) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporat

Entry into a Material Definitive Agreement, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 August 31, 2022 (August 26, 2022) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation

Employment Agreement This Employment Agreement (this “Agreement”), is entered into as of August 19, 2022 (the “Effective Date”) by and between DENTSPLY SIRONA Inc., a Delaware corporation (the “Company”) and Simon Campion (“Executive”) (collectively

Employment Agreement This Employment Agreement (this ?Agreement?), is entered into as of August 19, 2022 (the ?Effective Date?) by and between DENTSPLY SIRONA Inc.

Dentsply Sirona Appoints Simon Campion as Chief Executive Officer CHARLOTTE, N.C., August 25, 2022 (GLOBE NEWSWIRE) -- Dentsply Sirona Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that Simon Campion has been appointed Pres

Dentsply Sirona Appoints Simon Campion as Chief Executive Officer CHARLOTTE, N.C., August 25, 2022 (GLOBE NEWSWIRE) - Dentsply Sirona Inc. (?Dentsply Sirona? or the ?Company?) (Nasdaq: XRAY) today announced that Simon Campion has been appointed President and Chief Executive Officer and will join the Company?s Board of Directors (?Board?), effective September 12, 2022. He succeeds John Groetelaars,

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 August 25, 2022 (August 22, 2022) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation

Dentsply Sirona Receives Notice of Filing Delinquency from Nasdaq Charlotte, N.C., August 15, 2022 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that, as expected, it received written notification from The

Dentsply Sirona Receives Notice of Filing Delinquency from Nasdaq Charlotte, N.C., August 15, 2022 - DENTSPLY SIRONA Inc. (?Dentsply Sirona? or the "Company") (Nasdaq: XRAY) today announced that, as expected, it received written notification from The NASDAQ Stock Market (?Nasdaq?) on August 12, 2022 that the Company remains out of compliance with the Nasdaq Listing Rules because the Company has no

Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 August 15, 2022 (August 11, 2022) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 0-16211 CUSIP NUMBER 24906P109 (Check one): ☐Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 0-16211 CUSIP NUMBER 24906P109 (Check one): ?Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Period Ended: June 30, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 August 9, 2022 (August 4, 2022) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 August 4, 2022 Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (C

Dentsply Sirona Provides Business Update Company Provides Select Preliminary Second Quarter 2022 Results Company Provides Update on Previously Announced Investigation Company Provides Nasdaq Compliance Update CHARLOTTE, N.C., August 4, 2022 (GLOBE NE

Dentsply Sirona Provides Business Update Company Provides Select Preliminary Second Quarter 2022 Results Company Provides Update on Previously Announced Investigation Company Provides Nasdaq Compliance Update CHARLOTTE, N.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of inco

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 13320 Ballantyne Corporate Place, Charlotte North Carolina 28

Dentsply Sirona Inc. Conflict Minerals Report For the Year Ended December 31, 2021 Company Overview This report has been prepared by the management of DENTSPLY SIRONA Inc. (herein referred to as the “Company”, “we”, “us”, or “our”). The information i

EX-1.01 2 dentsplysironaformsdcmr2.htm EX-1.01 Dentsply Sirona Inc. Conflict Minerals Report For the Year Ended December 31, 2021 Company Overview This report has been prepared by the management of DENTSPLY SIRONA Inc. (herein referred to as the “Company”, “we”, “us”, or “our”). The information includes the activities of all majority- owned subsidiaries and variable interest entities that are requ

1 DENTSPLY SIRONA INC. KEY EMPLOYEE SEVERANCE BENEFITS PLAN (Effective as of May 25, 2022) ARTICLE 1. INTRODUCTION 1.1. Establishment, Effective Date and Purpose. Dentsply Sirona Inc. (the “Company”) has adopted the Dentsply Sirona Inc. Key Employee

1 DENTSPLY SIRONA INC. KEY EMPLOYEE SEVERANCE BENEFITS PLAN (Effective as of May 25, 2022) ARTICLE 1. INTRODUCTION 1.1. Establishment, Effective Date and Purpose. Dentsply Sirona Inc. (the ?Company?) has adopted the Dentsply Sirona Inc. Key Employee Severance Benefits Plan (the ?Plan?) effective as of May 25, 2022. The Plan is generally designed to provide separation pay and benefits to certain el

DENTSPLY SIRONA INC. SIXTH AMENDED AND RESTATED BY-LAWS TABLE OF CONTENTS Page ARTICLE I STOCKHOLDERS’ MEETINGS ...............................................................................1 Section 1. Annual Meetings ..............................

DENTSPLY SIRONA INC. SIXTH AMENDED AND RESTATED BY-LAWS TABLE OF CONTENTS Page ARTICLE I STOCKHOLDERS? MEETINGS ...............................................................................1 Section 1. Annual Meetings ............................................................................................... 1 Section 2. Special Meetings ......................................................

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 31, 2022 (May 24, 2022) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or org

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 26, 2022 (May 25, 2022) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or org

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 18, 2022 (May 12, 2022) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or org

Dentsply Sirona Receives Notice of Filing Delinquency from Nasdaq

Dentsply Sirona Receives Notice of Filing Delinquency from Nasdaq Charlotte, N.C., May 18, 2022 - DENTSPLY SIRONA Inc. (?Dentsply Sirona? or the "Company") (Nasdaq: XRAY) received written notification from The NASDAQ Stock Market (?Nasdaq?) on May 12, 2022 that the Company is no longer in compliance with the Nasdaq Listing Rules since the Company has not yet filed its Quarterly Report on Form 10-Q

Dentsply Sirona Reports Preliminary First Quarter 2022 Results

Dentsply Sirona Reports Preliminary First Quarter 2022 Results ?Net sales decreased (6.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 0-16211 CUSIP NUMBER 24906P109 (Check One) ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 0-16211 CUSIP NUMBER 24906P109 (Check One) ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: March 31, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transitio

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 10, 2022 (May 10, 2022) Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or org

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A proxy statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A proxy statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary proxy statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive proxy state

Interim Chief Executive Officer Employment Agreement

EX-10.1 2 ex101.htm EX-10.1 Interim Chief Executive Officer Employment Agreement This Interim Chief Executive Officer Employment Agreement (this “Agreement”), is entered into as of April 16, 2022 (the “Effective Date”) by and between DENTSPLY SIRONA Inc., a Delaware corporation (the “Company”) and John P. Groetelaars (“Executive”) (collectively referred to herein as the “Parties”). RECITALS Execut

Interim Chief Financial Officer Employment Agreement

Interim Chief Financial Officer Employment Agreement This Interim Chief Financial Officer Employment Agreement (this ?Agreement?), is entered into as of April 16, 2022 by and between DENTSPLY SIRONA Inc.

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 April 19, 2022 (April 16, 2022) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or

Dentsply Sirona Provides Corporate Update John Groetelaars Named Interim Chief Executive Officer Barbara Bodem Named Interim Chief Financial Officer Company Provides Update on Anticipated First Quarter Financial Results

Dentsply Sirona Provides Corporate Update John Groetelaars Named Interim Chief Executive Officer Barbara Bodem Named Interim Chief Financial Officer Company Provides Update on Anticipated First Quarter Financial Results CHARLOTTE, N.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A proxy statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A proxy statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary proxy statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive proxy state

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A proxy statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A proxy statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary proxy statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defi

Dentsply Sirona CFO Jorge Gomez Resigns to Assume CFO Position at Another Public Company CHARLOTTE, N.C., April 11, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq: XRAY) today announced that Executive Vice

exhibit991 Dentsply Sirona CFO Jorge Gomez Resigns to Assume CFO Position at Another Public Company CHARLOTTE, N.

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 April 11, 2022 (April 11, 2022) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or

Registered brands, trade names and logos are used. Even in particular cases, when they appear without their trademark, all corresponding legal rules and provisions apply. Clinicians may have been compensated for use of their experiences. Press Contac

Registered brands, trade names and logos are used. Even in particular cases, when they appear without their trademark, all corresponding legal rules and provisions apply. Clinicians may have been compensated for use of their experiences. Press Contact About Dentsply Sirona: Dentsply Sirona is the world?s largest manufacturer of professional dental products and technologies, with over a century of

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 April 6, 2022 (April 5, 2022) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A proxy statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A proxy statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary proxy statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defi

DENTSPLY SIRONA ANNOUNCES $150 MILLION ACCELERATED SHARE REPURCHASE PROGRAM

DENTSPLY SIRONA ANNOUNCES $150 MILLION ACCELERATED SHARE REPURCHASE PROGRAM CHARLOTTE, N.

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 March 9, 2022 (March 8, 2022) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Commission File Number 0-16211 DENTSPLY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 39-1434669 (State or other jurisdiction of incorporation or organization)

DENTSPLY SIRONA Inc. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY

Effective February 23, 2022 DENTSPLY SIRONA Inc. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY Purpose DENTSPLY SIRONA Inc. (the ?Company") believes that the granting of compensation to its members of the Board of Directors (the ?Board,? and members of the Board, ?Directors?) represents a powerful tool to attract, retain and reward Directors of the Company. This Director Compensation Policy (the ?Poli

INDEMNIFICATION AGREEMENT

INDEMNIFICATION AGREEMENT This Indemnification Agreement, dated as of , 20, is made by and between DENTSPLY SIRONA INC.

Subsidiaries of DENTSPLY SIRONA Inc. (the “Company”) - December 31, 2021

Exhibit 21.1 Subsidiaries of DENTSPLY SIRONA Inc. (the ?Company?) - December 31, 2021 1. Augma Bio Materials Ltd. (Israel, 20%) 2. Barracuda Partners, L.P. (Delaware, 25%) 3. Byte AU Pty. Ltd. (Australia) 4. Byte AU Unit Trust (Australia) 5. Byte LLC (Nevada) 6. Byteme Aligners Limited (United Kingdom) 7. Datum Biotech Ltd. (Israel) 8. Datum Dental Ltd. (Israel) 9. DeguDent GmbH (Germany) 10. Dent

Dentsply Sirona Reports Fourth Quarter and Full Year 2021 Results

Dentsply Sirona Reports Fourth Quarter and Full Year 2021 Results ?FY21 net sales increased 27.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 February 28, 2022 (February 28, 2022) Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporat

Registered brands, trade names and logos are used. Even in particular cases, when they appear without their trademark, all corresponding legal rules and provisions apply. Clinicians may have been compensated for use of their experiences. Press Contac

Registered brands, trade names and logos are used. Even in particular cases, when they appear without their trademark, all corresponding legal rules and provisions apply. Clinicians may have been compensated for use of their experiences. Press Contact About Dentsply Sirona: Dentsply Sirona is the world?s largest manufacturer of professional dental products and technologies, with over a century of

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 February 24, 2022 (February 22, 2022) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporat

XRAY / DENTSPLY SIRONA Inc / GENERATION INVESTMENT MANAGEMENT LLP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.

XRAY / DENTSPLY SIRONA Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Dentsply Sirona Inc. Title of Class of Securities: Common Stock CUSIP Number: 24906P109 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

January 12, 2022

January 12, 2022 VIA EDGAR SUBMISSION Mr. Brian Cascio Accounting Branch Chief Division of Corporation Finance Office of Life Sciences U.S. Securities & Exchange Commission Washington, D.C. 20549 Re: Dentsply Sirona Inc. Form 10-K for the Fiscal Year Ended December 31, 2020 Filed March 1, 2021 File No. 000-16211 Dear Mr. Cascio: Dentsply Sirona Inc. (?Company? or ?we?) hereby sets forth the follow

XRAY / DENTSPLY SIRONA Inc / GENERATION INVESTMENT MANAGEMENT LLP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 November 4, 2021 (November 4, 2021) Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Commission File Number 0-16211

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 39-1434669 (State or other jurisdiction of (I.R.S. Employer inco

Dentsply Sirona Reports Third Quarter 2021 Results

Dentsply Sirona Reports Third Quarter 2021 Results ?Revenue increased 19.4% to $1,069 million. Organic revenue increased 21.1% ?GAAP EPS increased to $0.47 vs $0.25 in 2020 ?Non-GAAP EPS increased to $0.68 vs $0.67 in 2020 ?GAAP operating income increased to $159 million vs $82 million in 2020 ?Non-GAAP operating income increased to $216 million vs $197 million in 2020 ?Operating cash flow decreas

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 Commission File Number 0-16211 DENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 39-1434669 (State or other jurisdiction of (I.R.S. Employer incorpora

Dentsply Sirona Reports Second Quarter 2021 Results

EX-99.1 2 dentsply8kq22021ex991.htm EX-99.1 Dentsply Sirona Reports Second Quarter 2021 Results •Revenue increased 117.3% to $1,067 million. Organic revenue increased 104.6% •GAAP EPS increased to $0.45 vs loss of ($0.44) in 2020 •Non-GAAP EPS increased to $0.71 vs loss of ($0.18) in 2020 •GAAP operating income increased to $155 million vs loss of ($104) million in 2020 •Non-GAAP operating income

August 5, 2021

EXHIBIT 18.1 August 5, 2021 Board of Directors Dentsply Sirona, Inc. 13320 Ballantyne Corporate Place Charlotte, NC 28277 Dear Directors: We are providing this letter to you for inclusion as an exhibit to Dentsply Sirona, Inc.?s (the ?Company?) Quarterly Report on Form 10-Q for the period ended June 30, 2021 (the ?Form 10-Q?) pursuant to Item 601 of Regulation S-K. We have been provided a copy of

August 5, 2021

EXHIBIT 18 August 5, 2021 Board of Directors Dentsply Sirona, Inc. 13320 Ballantyne Corporate Place Charlotte, NC 28277 Dear Directors: We are providing this letter to you for inclusion as an exhibit to Dentsply Sirona, Inc.?s (the ?Company?) Quarterly Report on Form 10-Q for the period ended June 30, 2021 (the ?Form 10-Q?) pursuant to Item 601 of Regulation S-K. We have been provided a copy of th

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 August 5, 2021 (August 5, 2021) Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or

Separation and Release of Claims Agreement

EXECUTION COPY Separation and Release of Claims Agreement This Separation and Release of Claims Agreement (?Agreement?) is entered into by and between DENTSPLY SIRONA Inc.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 June 1, 2021 (May 31, 2021) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or org

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of inco

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 13320 Ballantyne Corporate Place, Charlotte North Carolina 28

Dentsply Sirona Inc. Conflict Minerals Report For the Year Ended December 31, 2020

Dentsply Sirona Inc. Conflict Minerals Report For the Year Ended December 31, 2020 Company Overview This report has been prepared by the management of DENTSPLY SIRONA Inc. (herein referred to as the ?Company?, ?we?, ?us?, or ?our?). The information includes the activities of all majority-owned subsidiaries and variable interest entities that are required to be consolidated. The Company is the worl

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 27, 2021 (May 26, 2021) Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or org

Dentsply Sirona Reports First Quarter 2021 Results

Dentsply Sirona Reports First Quarter 2021 Results ?Revenue increased 17.5% to $1,027 million. Organic revenue increased 12.1% ?GAAP EPS increased to $0.53 vs loss of ($0.63) in 2020 ?Non-GAAP EPS increased 67.4% to $0.72 vs $0.43 in 2020 ?GAAP operating income increased to $154 million vs loss of ($125) million in 2020 ?Non-GAAP operating income increased 67.2% to $219 million vs $131 million in

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 39-1434669 (State or other jurisdiction of (I.R.S. Employer incorpor

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 May 6, 2021 (May 6, 2021) Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organ

- DEF 14A

DEF 14A 1 d102355ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A proxy statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary proxy statement ☐ Confidential, for Use of the Commission Only (as

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A proxy statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary proxy statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive proxy state

Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 39-1434669 (State or other jurisdiction of incorporation or organization)

Dentsply Sirona Reports Fourth Quarter and Full Year 2020 Results

Dentsply Sirona Reports Fourth Quarter and Full Year 2020 Results ?Q4 revenue decreased 2.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 March 1, 2021 (March 1, 2021) Date of Report (date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or o

Subsidiaries of DENTSPLY SIRONA Inc. (the “Company”) - December 31, 2020

EX-21.1 2 exhibit211q4202010-k.htm EX-21.1 Exhibit 21.1 Subsidiaries of DENTSPLY SIRONA Inc. (the “Company”) - December 31, 2020 1.Advanced Technology Research SRL (Italy) 2. Augma Bio Materials Ltd. (Israel, 20%) 3. Barracuda Partners, L.P. (Delaware, 25%) 4. Byte LLC (Nevada) 5. Byteme Aligners Aus. Pty. Ltd. (Australia) 6. Byteme Aligners Limited (United Kingdom) 7. CCRI, Inc. (Delaware) 8. Cer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3)*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)*

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Dentsply Sirona Inc. Title of Class of Securities: Common Stock CUSIP Number: 24906P109 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: